Researchers at the U.K. Health Security Agency estimated that one dose of the vaccine was 78% effective at protecting against infection 14 or more days after vaccination.
Some nations could be paying ten times the price of Paxlovid’s generic equivalent, as WHO chief calls for treatment access to battle acute and long COVID-19
Rich countries have secured almost three times as many courses of a World Health Organisation (WHO)-recommended COVID-19 medicine, Pfizer’s Paxlovid, according to new analysis from Oxfam and the People’s Vaccine Alliance.
Recent Comments